Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ.
J Clin Endocrinol Metab. 2006 Jun;91(6):2055-61. Epub 2006 Mar 21.PMID: 16551733 [PubMed - indexed for MEDLINE]Related articlesFree article